Switching biologics for psoriasis
The biological consequences of cutaneous laser surgery
Health economics and the modern management of psoriasis
British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010
Can sebum reduction predict acne outcome?
SIRT1 modulates expression of matrix metalloproteinases in human dermal fibroblasts
Emollient molecule effects on the drying stresses in human stratum corneum
Clinical and genetic features of 20 Japanese patients with vascular-type Ehlers–Danlos syndrome
Mapping of a novel locus for an autosomal recessive form of palmoplantar keratoderma on chromosome 3q27.2-q29
The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities
Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma
Abnormal DNA methylation in peripheral blood mononuclear cells from patients with vitiligo
Clinical diagnosis of toenail onychomycosis is possible in some patients: cross-sectional diagnostic study and development of a diagnostic rule
Tobacco smoking and hand eczema: a population-based study
Molecular mechanisms of nonablative fractionated laser resurfacing
Expression of human leucocyte antigen-G primarily targets affected skin of patients with psoriasis
Impaired lymphangiogenesis due to excess vascular endothelial growth factor-D/Flt-4 signalling in the skin of patients with systemic sclerosis
Notch signalling in primary cutaneous CD30+ lymphoproliferative disorders: a new therapeutic approach?
Nonclinical influences, beyond diagnosis and severity, on clinical decision making in dermatology: understanding the gap between guidelines and practice
Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study
A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis
The impact of photosensitivity disorders on aspects of lifestyle
Excimer laser vs. clobetasol propionate 0·05% ointment in prurigo form of atopic dermatitis: a randomized controlled trial, a pilot
Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy
Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept
Open trial of ciclosporin treatment for Stevens–Johnson syndrome and toxic epidermal necrolysis
Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous leishmaniasis in India
Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centre
Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year
Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria
A clinical isolate of Leishmania donovani with ITS1 sequence polymorphism as a cause of para-kala-azar dermal leishmaniasis in an Ethiopian human immunodeficiency virus-positive patient on highly active antiretroviral therapy
Cutaneous lymphangioma as a diagnostic clue for thoracic lymphangiomatosis
Rosacea fulminans with ocular involvement
Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care
Cutaneous symptoms in a patient with cardiofaciocutaneous syndrome and increased ERK phosphorylation in skin fibroblasts
Topical methyl aminolaevulinate–photodynamic therapy in erosive facial mycosis fungoides
Systemic therapies containing ethanol and gelatine excipients
A novel mutation in MBTPS2 causes ichthyosis follicularis, alopecia and photophobia (IFAP) syndrome in a Chinese family
Switching to adalimumab in patients with moderate to severe psoriasis who have failed on etanercept: a retrospective case cohort study
Diagnostic usefulness of a nested polymerase chain reaction assay for detecting Sarcoptes scabiei DNA in skin scrapings from clinically suspected scabies
Is serum amyloid A protein a better indicator of inflammation in severe psoriasis?
Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris?
Should ustekinumab really be used as first-line biological therapy in pityriasis rubra pilaris? Reply from authors
News and Notices